Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions
Giuseppe Caruso, Federica Tomao, Gabriella Parma, Mariateresa Lapresa, Francesco Multinu, Innocenza Palaia, Giovanni Aletti, Nicoletta Colombo
Topics & Concepts
MedicineIntensive care medicineMEDLINEOvarian cancerOncologyClinical trialCancerInternal medicinePolitical scienceLawPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentToxin Mechanisms and Immunotoxins